Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia
JAMA Network Open · 12.08.2026 · 9 (8) · e2628602
DOI: 10.1001/jamanetworkopen.2026.28602 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.08.2026. Verfasst von Daniel J Zheng und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Hispanic and non-Hispanic Black (hereafter, Black) children with acute myeloid leukemia (AML) have historically experienced worse survival outcomes compared with non-Hispanic White (hereafter, White) children. Understanding specific intermediate pathways underlying these outcome disparities is a critical step to directing interventional efforts and resources.
Objective
To compare survival outcomes by race and ethnicity in a large contemporary cohort of pediatric patients with AML and to examine presentation acuity, frontline organ toxic effects, and relapse as potential mediators of any observed outcome disparities. Design, Setting, and Participants This retrospective cohort study was analyzed from April 2025 to January 2026 and included 13 US children’s hospitals across 10 states participating in the Real-World Epidemiology of Acute Leukemia-AML cohort. Participants included children treated for de novo AML from January 2011 through May 2024. Exposure Race and ethnicity (Black, Hispanic, and White). Main Outcomes and Measures The main outcome was overall survival (OS), defined as the time from AML diagnosis until death from any cause.
Results
The study cohort included 773 children (median [IQR] age, 9 [2-14] years; 402 males [52.0%]), of whom 125 (16.2%) were Black, 237 (30.7%) were Hispanic, and 411 (53.2%) were White (median [IQR] follow-up, 51.2 [25.7-86.9] months), treated for de novo AML. Among the patients, Black (5-year OS, 61.1% [95% CI, 52.6%-71.0%]; adjusted hazard ratio [AHR], 1.55 [95% CI, 1.26-1.91]) and Hispanic (5-year OS, 65.4% [95% CI, 58.9%-72.5%]; AHR, 1.32 [95% CI, 1.03-1.68]) children had worse OS compared with White children (5-year OS, 70.0% [95% CI, 65.2%-75.1%]). Compared with White patients, Black patients had increased risk of higher cardiovascular (adjusted risk ratio [ARR], 2.09 [95% CI, 1.23-3.56]), respiratory (ARR, 1.36 [95% CI, 1.05-1.77]), and renal (ARR, 3.08 [95% CI, 1.02-9.32]) acuity at presentation. There were no statistically significant increases in severe frontline organ toxic effects or relapse rates by race and ethnicity. Cardiovascular acuity (AHR, 1.83 [95% CI, 1.51-2.22]) and respiratory acuity (AHR, 1.43 [95% CI, 1.15-1.77]) at presentation were independently associated with all-cause mortality. Cardiovascular acuity (proportion mediated, 14%) and respiratory acuity (proportion mediated, 8%) at presentation partially mediated the total absolute survival difference between Black and White children. Conclusions and Relevance In this cohort study of pediatric patients with AML, differential cardiovascular and respiratory acuity at presentation were partial mediators of outcome disparities for Black children with AML. Other intermediates along the care continuum should be identified to account for the remainder of the observed outcomes and to prioritize focus areas for interventional efforts to mitigate the survival differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University, Palo Alto, California.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Zheng, D. J., Khuong, L., Aftandilian, C., Bona, K., Caywood, E. H., Elgarten, C. W., Fisher, B. T., Gathers, C. L., Ghosh, T., Gramatges, M. M., Hettinger, G., Henry, M. R., Huang, Y. V., Li, Y., Maloney, K., Mian, A., Miller, T. P., Modi, A., Mody, R., …, & Getz, K. D. (2026). Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia. JAMA Network Open, 9(8), e2628602. https://doi.org/10.1001/jamanetworkopen.2026.28602
Vancouver
Zheng DJ, Khuong L, Aftandilian C, Bona K, Caywood EH, Elgarten CW, et al. Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia. JAMA Network Open. 2026;9(8):e2628602. doi:10.1001/jamanetworkopen.2026.28602
BibTeX
@article{Zheng2026,
author = {Zheng, Daniel J and Khuong, Long and Aftandilian, Catherine and Bona, Kira and Caywood, Emi H and Elgarten, Caitlin W and Fisher, Brian T and Gathers, Cody-Aaron L and Ghosh, Taumoha and Gramatges, M Monica and Hettinger, Gary and Henry, Meret R and Huang, Yuan-Shung V and Li, Yimei and Maloney, Kelly and Mian, Amir and Miller, Tamara P and Modi, Arunkumar and Mody, Rajen and Myers, Regina M and Newman, Haley and Ortiz, Jose and Seif, Alix E and Smith, Caroline and Stokke, Jamie and Winick, Naomi and Wilkes, Jennifer J and Wong, Victor and Aplenc, Richard and Getz, Kelly D},
title = {Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {8},
pages = {e2628602},
doi = {10.1001/jamanetworkopen.2026.28602}
}
EUVIMED